Linvesta Emp 10mg/5mg Tablet
₨ 377
About this product
Overview
Linvesta Emp 10mg/5mg Tablet is a combination medication that contains two active ingredients: Empagliflozin and Linagliptin. It is commonly prescribed for the management of type 2 diabetes by addressing blood sugar levels through different mechanisms.
Active Ingredients
- Empagliflozin (10mg):
- Empagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor. It works by reducing glucose reabsorption in the kidneys, leading to increased glucose excretion in urine.
- Linagliptin (5mg):
- Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It enhances the action of incretin hormones, leading to increased insulin release and reduced glucagon secretion.
Used For
- Type 2 Diabetes Management: Linvesta Emp is prescribed to individuals with type 2 diabetes to help control blood sugar levels.
- Dual Action: The combination of Empagliflozin and Linagliptin provides dual action by addressing glucose reabsorption and enhancing incretin effects.
Dosage and Administration
- The dosage is typically determined by healthcare providers based on individual response and medical condition.
- Tablets are usually taken orally, with or without food, as directed by the healthcare provider.
Side Effects
Common side effects may include urinary tract infections, increased urination, and nasopharyngitis. Consult with a healthcare professional if any adverse reactions persist.
When Not to Use
- Kidney Impairment: Linvesta Emp is not recommended for individuals with severe kidney impairment.
- Allergies: Individuals with known allergies to Empagliflozin, Linagliptin, or related components should avoid this medication.
Precautions and Warnings
- Dehydration: Caution is advised in individuals at risk of dehydration, such as those taking diuretics or with significant fluid loss.
- Pancreatitis: Monitor for signs of pancreatitis, such as persistent abdominal pain.
Frequently asked questions
Q1: How does Linvesta Emp 10mg/5mg Tablet help in managing type 2 diabetes?
Linvesta Emp contains Empagliflozin and Linagliptin. Empagliflozin reduces glucose reabsorption in the kidneys, and Linagliptin enhances incretin effects, leading to improved blood sugar control in individuals with type 2 diabetes.
Q2: What is the recommended dosage for Linvesta Emp 10mg/5mg Tablet?
The recommended dosage is determined by healthcare providers based on individual response and medical condition. Adherence to the prescribed dosage is crucial for effective diabetes management.
Q3: Can Linvesta Emp 10mg/5mg Tablet be taken as a monotherapy for diabetes?
Linvesta Emp is often prescribed as part of a comprehensive treatment plan for type 2 diabetes. Consult with your healthcare provider for personalized advice on diabetes management.
Q4: Are there specific precautions for individuals with kidney impairment using Linvesta Emp?
Linvesta Emp is not recommended for individuals with severe kidney impairment. Regular monitoring and adjustment of the dosage may be necessary. Consult with your healthcare provider for personalized advice.
Q5: Can Linvesta Emp 10mg/5mg Tablet be taken with other diabetes medications?
Inform your healthcare provider about all medications, including over-the-counter drugs and supplements, to avoid potential interactions. Your healthcare provider can guide you on the appropriate combination therapies.
This information is for general awareness only. It does not replace advice from your doctor or pharmacist. Always read the leaflet and follow the directions you were given.
Customer reviews
You must be logged in to post a review.
Reviews
Clear filtersThere are no reviews yet.